Search
Edesa Biotech Inc
EDSAAdd to Watchlist
4.000USD
+0.140+3.63%
Market hours 10/05, 11:27（ET）
38.52MMarket Cap
LossP/E TTM
Edesa Biotech Inc (EDSA) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Edesa Biotech Inc in the past month.
Buy
0 Strong Buy
3 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
13.500USD+249.74%
EDSA Analyst Recommendation Trends
In the current month, EDSA has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EDSA average Analyst price target in the last month is 13.500.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
3
3
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
2
2
2
2
2
2
EDSA Analyst Rating for Peer Comparison
Updated: Oct 4, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
IQVIA Holdings Inc
IQV
7
12
6
0
0
25
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, EDSA EPS is projected to reach -0.583 in FY2026Q4, following reported EPS of -0.600 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.45
-0.26
-0.58
-0.58
Actual
-0.28
-0.49
-0.60
--
Surprise
+37.35%
-89.95%
-3.51%
--
FAQs
What is Edesa Biotech Inc's price target?
Analysts forecast that Edesa Biotech Inc's price target is USD 13.50, with the highest forecast at USD 21.00 and the lowest forecast at USD 5.00.
How have Edesa Biotech IncEDSA's recent earnings per share performed?
The market expectation was USD -0.60, while Edesa Biotech IncEDSA's earnings per share (EPS) for the previous quarter was USD -0.49. EPS for the next quarter is expected at USD -0.58.
What is the analyst rating for Edesa Biotech Inc?
Based on the ratings of Edesa Biotech Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.